- Home
- RDIB vs SOPH Comparison
RDIB vs SOPH Comparison
Compare RDIB & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDIB
- SOPH
- Stock Information
- Founded
- RDIB 1937
- SOPH 2011
- Country
- RDIB United States
- SOPH Switzerland
- Employees
- RDIB N/A
- SOPH N/A
- Industry
- RDIB Movies/Entertainment
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDIB Consumer Discretionary
- SOPH Health Care
- Exchange
- RDIB Nasdaq
- SOPH Nasdaq
- Market Cap
- RDIB 259.2M
- SOPH 231.8M
- IPO Year
- RDIB N/A
- SOPH 2021
- Fundamental
- Price
- RDIB $10.99
- SOPH $4.20
- Analyst Decision
- RDIB
- SOPH
- Analyst Count
- RDIB 0
- SOPH 0
- Target Price
- RDIB N/A
- SOPH N/A
- AVG Volume (30 Days)
- RDIB 10.7K
- SOPH 135.3K
- Earning Date
- RDIB 11-13-2025
- SOPH 11-04-2025
- Dividend Yield
- RDIB N/A
- SOPH N/A
- EPS Growth
- RDIB N/A
- SOPH N/A
- EPS
- RDIB N/A
- SOPH N/A
- Revenue
- RDIB $219,213,000.00
- SOPH $69,688,000.00
- Revenue This Year
- RDIB $5.21
- SOPH $16.60
- Revenue Next Year
- RDIB $11.45
- SOPH $19.09
- P/E Ratio
- RDIB N/A
- SOPH N/A
- Revenue Growth
- RDIB 7.59
- SOPH 7.32
- 52 Week Low
- RDIB $5.78
- SOPH $2.58
- 52 Week High
- RDIB $14.95
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- RDIB 45.53
- SOPH 52.66
- Support Level
- RDIB $10.22
- SOPH $3.93
- Resistance Level
- RDIB $11.55
- SOPH $4.70
- Average True Range (ATR)
- RDIB 0.57
- SOPH 0.33
- MACD
- RDIB -0.04
- SOPH -0.04
- Stochastic Oscillator
- RDIB 37.38
- SOPH 30.16
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.